Refractory Anaphylaxis: Data From the European Anaphylaxis Registry.

Front Immunol

Department of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.

Published: October 2020

Refractory anaphylaxis (unresponsive to treatment with at least two doses of minimum 300 μg adrenaline) is a rare and often fatal hypersensitivity reaction. Comprehensive data on its definition, prevalence, and risk factors are missing. Using the data from the European Anaphylaxis Registry (11,596 cases in total) we identified refractory anaphylaxis cases ( = 42) and analyzed these in comparison to a control group of severe anaphylaxis cases ( = 4,820). The data show that drugs more frequently elicited refractory anaphylaxis (50% of cases, < 0.0001) compared to other severe anaphylaxis cases (19.7%). Cases elicited by insects ( = 8) were more often due to bees than wasps in refractory cases (62.5 vs. 19.4%, = 0.009). The refractory cases occurred mostly in a perioperative setting (45.2 vs. 9.05, < 0.0001). Intramuscular adrenaline (as a first line therapy) was administered in 16.7% of refractory cases, whereas in 83.3% of cases it was applied intravenously (significantly more often than in severe anaphylaxis cases: 12.3%, < 0.0001). Second line treatment options (e.g., vasopression with dopamine, methylene blue, glucagon) were not used at all for the treatment of refractory cases. The mortality rate in refractory anaphylaxis was significantly higher (26.2%) than in severe cases (0.353%, < 0.0001). Refractory anaphylaxis is associated with drug-induced anaphylaxis in particular if allergens are given intravenously. Although physicians frequently use adrenaline in cases of perioperative anaphylaxis, not all patients are responding to treatment. Whether a delay in recognition of anaphylaxis is responsible for the refractory case or whether these cases are due to an overflow with mast cell activating substances-requires further studies. Reasons for the low use of second-line medication (i.e., methylene blue or dopamine) in refractory cases are unknown, but their use might improve the outcome of severe refractory anaphylaxis cases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842952PMC
http://dx.doi.org/10.3389/fimmu.2019.02482DOI Listing

Publication Analysis

Top Keywords

refractory anaphylaxis
28
anaphylaxis cases
20
refractory cases
20
cases
17
anaphylaxis
14
refractory
13
severe anaphylaxis
12
data european
8
european anaphylaxis
8
anaphylaxis registry
8

Similar Publications

Do No Harm: An Ethical Approach to Refractory Anaphylaxis to Chemotherapy.

Ann Allergy Asthma Immunol

November 2024

Section of Allergy and Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • Anaphylaxis is a life-threatening allergic reaction, and understanding its triggers is crucial for preventing severe cases known as refractory anaphylaxis (RA).
  • A study analyzed data from 1,378 patients diagnosed with anaphylaxis, finding that 3.3% had RA, with a history of anaphylaxis being the strongest risk factor.
  • Other factors such as the use of beta-blockers/ACE inhibitors, exposure to IV contrast agents, and symptoms of low blood pressure were also linked to increased severity, highlighting the need for prompt treatment to improve patient outcomes.
View Article and Find Full Text PDF

Background: Autoimmune diseases in children pose therapeutic challenges due to their refractory nature and the associated morbidity. Rituximab (RTX), a monoclonal antibody targeting CD20, has emerged as a promising steroid-sparing therapy for various autoimmune disorders by depleting B cells. However, its indications and safety in pediatric populations in our region remain insufficiently studied.

View Article and Find Full Text PDF

Successful management of anaphylactic shock prior to elective cesarean delivery: a case report.

JA Clin Rep

October 2024

Department of Obstetric Anesthesiology, Center for Maternal-Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.

Article Synopsis
  • Anaphylactic cardiovascular collapse during pregnancy can be worsened by aortocaval compression and neuraxial anesthesia, with Japanese practices favoring post-anesthesia antibiotic administration, contrary to recommendations.
  • A 24-year-old pregnant woman experienced anaphylactic symptoms after receiving cefazolin before spinal anesthesia for a scheduled repeat cesarean, leading to emergency surgery under general anesthesia.
  • The successful delivery of a healthy neonate and the mother's improved condition post-surgery highlight the necessity of timely antibiotic administration and the effectiveness of swift emergency interventions in severe allergic reactions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!